Chinese Journal of Cancer Research
Vol 36, No 3 (June 2024)
Contents
Guidelines
CSCO guidelines for colorectal cancer version 2024: Updates and discussions
Liubo Chen, Hanguang Hu, Ying Yuan, Shanshan Weng
Consensus and Expert Recommendation
Evidence-based expert consensus on clinical management of safety of Bruton’s tyrosine kinase inhibitors (2024)
Zaiwei Song, Dan Jiang, Lingling Yu, Yixuan Chen, Daobin Zhou, Yue Li, Depei Wu, Lingli Zhang, Liyan Miao, Jun Ma, Jun Zhu, Hongmei Jing, Rongsheng Zhao, on behalf of the Steering Committee, the Consensus Panel and the Evidence Synthesis Group; Evidence-based Pharmacy Professional Committee of Chinese Pharmaceutical Association (CPA), Hospital Pharmacy Professional Committee of Chinese Pharmaceutical Association (CPA), Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society (CPS), Expert Committee on Lymphoma of Chinese Society of Clinical Oncology (CSCO), Expert Committee on Leukemia of Chinese Society of Clinical Oncology (CSCO), Society of Integrative Cardio-Oncology of China Anti-Cancer Association (CACA), Chinese Society of Hematology of Chinese Medical Association (CMA), Hospital Pharmacy Professional Committee of Cross-Straits Medicine Exchange Association (SMEA)
Original Article
Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors
Jian Li, Ye Xu, Aimin Zang, Yunong Gao, Quanli Gao, Yanqiao Zhang, Dong Wang, Jianming Xu, Ying Yuan, Haiping Jiang, Jieer Ying, Chunmei Shi, Yanhong Deng, Jing Wang, Tianshu Liu, Yi Huang, Xiaoping Qian, Yueyin Pan, Ying Cheng, Sheng Hu, Jin Wang, Mengyue Shi, Ke Wang, Han Hu, Lin Shen
Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II study
Guojie Feng, Jiao Li, Nuo Yu, Ziyu Zheng, Xiongtao Yang, Lei Deng, Tao Zhang, Wenqing Wang, Wenyang Liu, Jianyang Wang, Qinfu Feng, Jima Lyu, Zefen Xiao, Zongmei Zhou, Nan Bi, Jianjun Qin, Xin Wang
Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis
Yifei Wang, Yidan Ma, Lei He, Jun Du, Xiaoguang Li, Peng Jiao, Xiaonan Wu, Xiaomao Xu, Wei Zhou, Li Yang, Jing Di, Changbin Zhu, Liming Xu, Tianlin Sun, Lin Li, Dongge Liu, Zheng Wang
Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study
Huimin Yin, Xianqiang Wang, Shouhua Zhang, Shaohua He, Wenli Zhang, Hongting Lu, Yizhen Wang, Jing He, Chunlei Zhou
Review Article
Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer
Zhifei Li, Huan Zhao, Huihui Hu, Haili Shang, Yongjing Ren, Wenhui Qiu, Hao Su, Huifang Lyu, Xiaobing Chen
Unlocking epigenetics for precision treatment of Ewing’s sarcoma
Zhehao Fan, Shuangshuang Dong, Ning Wang, Muhammad Babar Khawar, Jingcheng Wang, Haibo Sun
Brief Communication
Unraveling links between aging, circadian rhythm and cancer: Insights from evidence-based analysis
Dechao Feng, Yuhan Xiao, Jie Wang, Ruicheng Wu, Zhouting Tuo, Koo Han Yoo, Wuran Wei, Dilinaer Wusiman, Zhipeng Wang, Dengxiong Li, Yubo Yang, William C. Cho, Mang Ke
